CLINICAL_TRIALS
trial_result
· 2018-11-26
Clinical Trial Update: Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone [Phase 3]
Summary
Phase 3 clinical trial comparing blonanserin to risperidone in schizophrenia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma (Suzhou) Co., Ltd. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2018-11-26